LINC01836

Across TCGA pan-cancer cohorts, LINC01836 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated LINC01836 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC01836 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01836 expression acts as an unfavorable survival marker, although some lineages such as BRCA and UCS show a favorable association.

COAD, ACC, and PAAD are the cancer types where LINC01836 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.507	0.726	<.001	79	view →
ACC	OS	Median	All	0.782	0.954	<.001	74	view →
PAAD	DFS	Median	All	0.369	0.566	.005	34	view →
BRCA	OS	Tertile	II,III,IV	0.971	0.937	.008	31	view →
ESCA	OS	Median	IV	0.222	0.698	.006	27	view →
UCS	DFS	Tertile	IV	0.832	0.239	.024	26	view →
LIHC	OS	Quartile	All	0.333	0.664	<.001	19	view →
SARC	DFS	Tertile	All	0.675	0.508	.002	17	view →
KIRC	DFS	Median	All	0.902	0.841	.005	16	view →
THYM	DFS	Quartile	All	1.000	0.666	.022	14	view →
TGCT	DFS	Median	All	0.705	0.890	.004	14	view →
LGG	OS	Tertile	All	0.742	0.899	.008	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

LINC01836–COAD (OS)

Open the COAD breakdown →